Tag
A new New York Times perspective piece on whether we’re underselling the various COVID-19 vaccines had public health Twitter abuzz…
Journalists covering the COVID-19 vaccine rollout should watch out on Jan. 21 for the Ad Council’s unveiling of an advertising…
Pfizer made waves Monday with its announcement that its COVID-19 vaccine, developed with partner BioNTech, is “strongly effective,” with a…
Photo: Photo: VCU Capital News Service via Flickr The race for a COVID-19 is heating up. At least two COVID-19…
I’ve written in previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The…
It’s been a dizzying task for reporters trying to keep up with the development of COVID-19 vaccines. There are the…
The timeless advice sometimes attributed to Deep Throat or Bob Woodard and Carl Bernstein to “follow the money” certainly applies…
As various COVID-19 vaccine candidates make their way through clinical trials — see this nice update on where things stand…
To showcase how schools could reopen safely this year, Centers for Disease Control and Prevention director Robert Redfield, M.D., highlighted…
As we start moving into fall and winter, Americans are certain to be facing a continuation of COVID-19, the disease…